Bronchodilator Responsiveness in Preterm-Born Children With Chronic Lung Disease: Importance of Individualized Testing. | ClinicLens
Children born preterm with chronic lung disease of Immaturity (CLDI) frequently present with obstructive lung function, yet optimal bronchodilator therapy remains uncertain. Previous studies focused on β2-agonists, while evidence for muscarinic antagonist therapy is limited. We c
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.